Amdocs Ltd
NASDAQ:DOX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
74.95
94.08
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
DOX
stock under the Base Case scenario is
106.74
USD.
Compared to the current market price of 79.35 USD,
Amdocs Ltd
is
Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Amdocs Ltd.
| US |
|
International Business Machines Corp
NYSE:IBM
|
|
| IE |
|
Accenture PLC
NYSE:ACN
|
|
| IN |
|
Tata Consultancy Services Ltd
NSE:TCS
|
|
| IN |
|
Infosys Ltd
NSE:INFY
|
|
| IN |
|
HCL Technologies Ltd
NSE:HCLTECH
|
|
| JP |
|
Fujitsu Ltd
TSE:6702
|
|
| JP |
|
NEC Corp
TSE:6701
|
|
| US |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
|
| JP |
|
NTT Data Corp
TSE:9613
|
|
| JP |
N
|
NTT Data Group Corp
DUS:NT5
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
A persistent slowdown in telecom capital expenditures could reduce demand for Amdocs’ software and services, as major carriers defer large-scale billing and operational support modernization projects in favor of cost-containment initiatives.
Competition from both specialized cloud-native providers and internal developer teams at telecom operators threatens Amdocs’ traditional on-premises approach, potentially eroding pricing power and jeopardizing new contract wins.
Margin pressures may intensify if Amdocs continues investing heavily in 5G and digital transformation solutions without guaranteeing substantial immediate returns, leading to potentially lower profitability and shareholder concerns.
Long-term, stable relationships with top-tier telecom operators ensure recurring revenue and high switching costs, reinforcing Amdocs’ position as a trusted billing and customer experience partner amid industry transitions.
Amdocs’ leadership in convergent real-time billing and OSS/BSS solutions positions the firm to benefit from ongoing 5G rollouts, as carriers upgrade their systems to manage complex, high-bandwidth services and new revenue models.
The company’s track record of strategic acquisitions, such as its expansion into the media sector, suggests it can capture emerging opportunities beyond its core telecom markets and diversify its revenue base over time.
Revenue & Expenses Breakdown
Amdocs Ltd
Balance Sheet Decomposition
Amdocs Ltd
| Current Assets | 1.7B |
| Cash & Short-Term Investments | 342.5m |
| Receivables | 956.6m |
| Other Current Assets | 352.8m |
| Non-Current Assets | 4.7B |
| PP&E | 961.3m |
| Intangibles | 3B |
| Other Non-Current Assets | 675.5m |
| Current Liabilities | 1.4B |
| Accounts Payable | 407.1m |
| Accrued Liabilities | 676.8m |
| Other Current Liabilities | 267.3m |
| Non-Current Liabilities | 1.5B |
| Long-Term Debt | 646.7m |
| Other Non-Current Liabilities | 830.9m |
Free Cash Flow Analysis
Amdocs Ltd
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Amdocs Ltd
|
Revenue
|
4.6B
USD
|
|
Cost of Revenue
|
-2.9B
USD
|
|
Gross Profit
|
1.7B
USD
|
|
Operating Expenses
|
-928.5m
USD
|
|
Operating Income
|
801.7m
USD
|
|
Other Expenses
|
-257.3m
USD
|
|
Net Income
|
544.4m
USD
|
DOX Profitability Score
Profitability Due Diligence
Amdocs Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Amdocs Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
DOX Solvency Score
Solvency Due Diligence
Amdocs Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Amdocs Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DOX Price Targets Summary
Amdocs Ltd
According to Wall Street analysts, the average 1-year price target for
DOX
is 102.47 USD
with a low forecast of 87.87 USD and a high forecast of 116.55 USD.
Dividends
Current shareholder yield for
DOX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DOX
stock under the Base Case scenario is
106.74
USD.
Compared to the current market price of 79.35 USD,
Amdocs Ltd
is
Undervalued by 26%.